Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Biomaterials. 2009 Sep 30;31(2):339–344. doi: 10.1016/j.biomaterials.2009.09.033

Table 1.

Median survival times from date of human small cell lung tumor inoculation. Free etoposide was administered on days 0, 1, and 2, whereas particles were administered on day 0 only. Mice were sacrificed when tumors reached 1 cm3

Treatment Administration Route# Median survival time (days) n
Blank PEG-PSA particles IT 13 5
Free etoposide IT 16 5
Free etoposide IP 11 5
Etoposide in PEG-PSA particles IT 47* 6
#

IT = intratumoral; IP = intraperitoneal

*

statistically significant compared to other treatments (p < 0.05).